189 related articles for article (PubMed ID: 2505783)
1. Chloroacetaldehyde and its contribution to urotoxicity during treatment with cyclophosphamide or ifosfamide. An experimental study/short communication.
Pohl J; Stekar J; Hilgard P
Arzneimittelforschung; 1989 Jun; 39(6):704-5. PubMed ID: 2505783
[TBL] [Abstract][Full Text] [Related]
2. Prevention of urotoxic side effects by regional detoxification with increased selectivity of oxazaphosphorine cytostatics.
Brock N; Pohl J
IARC Sci Publ; 1986; (78):269-79. PubMed ID: 3108156
[TBL] [Abstract][Full Text] [Related]
3. Contribution of flavonoid antioxidants to the preventive effect of mesna in cyclophosphamide-induced cystitis in rats.
Ozcan A; Korkmaz A; Oter S; Coskun O
Arch Toxicol; 2005 Aug; 79(8):461-5. PubMed ID: 15800758
[TBL] [Abstract][Full Text] [Related]
4. Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention. 2. Comparative study on the uroprotective efficacy of thiols and other sulfur compounds.
Brock N; Pohl J; Stekar J
Eur J Cancer Clin Oncol; 1981 Nov; 17(11):1155-63. PubMed ID: 7199463
[No Abstract] [Full Text] [Related]
5. Detoxification of urotoxic oxazaphosphorines by sulfhydryl compounds.
Brock N; Pohl J; Stekar J
J Cancer Res Clin Oncol; 1981; 100(3):311-20. PubMed ID: 6792207
[TBL] [Abstract][Full Text] [Related]
6. Influence of mesna on urotoxic effects of selected bromosubstituted analogs of ifosfamide.
Kuśnierczyk H; Konarski L; Kowalski P; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1997; 45(1):79-85. PubMed ID: 9090445
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of mesna (2-mercaptoethane sodium sulfonate) as a uroprotectant in patients with hemorrhagic cystitis receiving further oxazaphosphorine chemotherapy.
Andriole GL; Sandlund JT; Miser JS; Arasi V; Linehan M; Magrath IT
J Clin Oncol; 1987 May; 5(5):799-803. PubMed ID: 3106585
[TBL] [Abstract][Full Text] [Related]
8. Ternatin, a flavonoid, prevents cyclophosphamide and ifosfamide-induced hemorrhagic cystitis in rats.
Vieira MM; Macêdo FY; Filho JN; Costa AC; Cunha AN; Silveira ER; Brito GA; Ribeiro RA
Phytother Res; 2004 Feb; 18(2):135-41. PubMed ID: 15022166
[TBL] [Abstract][Full Text] [Related]
9. Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide.
Brock N; Stekar J; Pohl J; Niemeyer U; Scheffler G
Arzneimittelforschung; 1979; 29(4):659-61. PubMed ID: 114192
[TBL] [Abstract][Full Text] [Related]
10. Amifostine and glutathione prevent ifosfamide- and acrolein-induced hemorrhagic cystitis.
Batista CK; Mota JM; Souza ML; Leitão BT; Souza MH; Brito GA; Cunha FQ; Ribeiro RA
Cancer Chemother Pharmacol; 2007 Jan; 59(1):71-7. PubMed ID: 16708234
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of ketamine against hemorrhagic cystitis in rats receiving ifosfamide.
Ozguven AA; Yılmaz O; Taneli F; Ulman C; Vatansever S; Onag A
Indian J Pharmacol; 2014; 46(2):147-51. PubMed ID: 24741183
[TBL] [Abstract][Full Text] [Related]
12. Prevention of further cyclophosphamide induced hemorrhagic cystitis by hyperbaric oxygen and mesna in guinea pigs.
Korkmaz A; Oter S; Deveci S; Goksoy C; Bilgic H
J Urol; 2001 Sep; 166(3):1119-23. PubMed ID: 11490309
[TBL] [Abstract][Full Text] [Related]
13. Contribution of antioxidants to preventive effect of mesna in cyclophosphamide-induced hemorrhagic cystitis in rats.
Yildirim I; Korkmaz A; Oter S; Ozcan A; Oztas E
Cancer Chemother Pharmacol; 2004 Nov; 54(5):469-73. PubMed ID: 15232716
[TBL] [Abstract][Full Text] [Related]
14. Role of MGMT in protecting against cyclophosphamide-induced toxicity in cells and animals.
Hansen RJ; Ludeman SM; Paikoff SJ; Pegg AE; Dolan ME
DNA Repair (Amst); 2007 Aug; 6(8):1145-54. PubMed ID: 17485251
[TBL] [Abstract][Full Text] [Related]
15. Urinary excretion of ifosfamide, 4-hydroxyifosfamide, 3- and 2-dechloroethylifosfamide, mesna, and dimesna in patients on fractionated intravenous ifosfamide and concomitant mesna therapy.
Kurowski V; Wagner T
Cancer Chemother Pharmacol; 1997; 39(5):431-9. PubMed ID: 9054957
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 contributes to functional changes seen on experimental hemorrhagic cystitis induced by ifosfamide in rat urinary bladder.
Macedo FY; Mourão LT; Palheta RC; Jucá DM; Lima RC; Neto Jde S; Magalhães PJ; Santos AA; Souza MH; Brito GA; Ribeiro RA
Cancer Chemother Pharmacol; 2011 Apr; 67(4):935-43. PubMed ID: 20602232
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-alpha and interleukin-1beta mediate the production of nitric oxide involved in the pathogenesis of ifosfamide induced hemorrhagic cystitis in mice.
Ribeiro RA; Freitas HC; Campos MC; Santos CC; Figueiredo FC; Brito GA; Cunha FQ
J Urol; 2002 May; 167(5):2229-34. PubMed ID: 11956484
[TBL] [Abstract][Full Text] [Related]
18. Continuous subcutaneous administration of mesna to prevent ifosfamide-induced hemorrhagic cystitis.
Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J
Semin Oncol; 1996 Jun; 23(3 Suppl 6):97-8. PubMed ID: 8677458
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic intravesical instillation of epinephrine prevents cyclophosphamide-induced hemorrhagic cystitis in rats.
Chow YC; Yang S; Huang CJ; Tzen CY; Su YH; Wang PS
Exp Biol Med (Maywood); 2007 Apr; 232(4):565-70. PubMed ID: 17392493
[TBL] [Abstract][Full Text] [Related]
20. Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--I. Experimental studies on the urotoxicity of alkylating compounds.
Brock N; Pohl J; Stekar J
Eur J Cancer (1965); 1981 Jun; 17(6):595-607. PubMed ID: 7308258
[No Abstract] [Full Text] [Related]
[Next] [New Search]
